Literature DB >> 20948392

Treatment of resistant hypertension.

Eduardo Pimenta, David A Calhoun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20948392     DOI： 10.1097/HJH.0b013e32833eafa3

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  5 in total

1.  Use of enoximone in management of anaphylaxis complicated by labetalol use.

Authors:  Sophie Hayhoe; Vilas Navapurkar; Andrew Conway Morris
Journal:  BMJ Case Rep       Date:  2015-10-26

Review 2.  Sodium-retaining effect of insulin in diabetes.

Authors:  Michael W Brands; M Marlina Manhiani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-03       Impact factor: 3.619

3.  Resistant hypertension: an approach to management in primary care.

Authors:  Julian P Yaxley; Sam V Thambar
Journal:  J Family Med Prim Care       Date:  2015 Apr-Jun

Review 4.  Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

Authors:  Juan Carlos Yugar-Toledo; Rodrigo Modolo; Ana Paula de Faria; Heitor Moreno
Journal:  Vasc Health Risk Manag       Date:  2017-10-16

5.  Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.

Authors:  Hiroshi Itoh; Sadayoshi Ito; Hiromi Rakugi; Yasuyuki Okuda; Satoshi Nishioka
Journal:  Hypertens Res       Date:  2019-06-25       Impact factor: 3.872
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.